Vimarsana
Biggest News Aggregation in the World

Page 7 - Mark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Diagnostics Today - Breaking & Trending Today

BioMark Diagnostics, Inc.: BioMark Provides Financial Results for the Year Ended March 31, 2022, and Recent Corporate Highlights - Vimarsana News

BioMark Diagnostics, Inc.: BioMark Provides Financial Results for the Year Ended March 31, 2022, and Recent Corporate Highlights

Published: July 14, 2022

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an oncology-focused company with advanced

Source: finanznachrichten.de
Related Topics:
United KingdomBritish ColumbiaRashid BuxRashid Ahmed BuxCompany Stock Option PlanLaval UniversityBritish Columbia Newsfile CorpWhile The CompanyIcahn School Of Medicine At Mount SinaiBiomark Diagnostics IncBiomark Diagnostic Solutions IncMark DiagnosticsBiomark Diagnostic SolutionsNational Research CouncilCanada Industrial Research Assistance ProgramPfizer CanadaBiomark DiagnosticsQuebec CityStock OptionStock Option PlanCorporate EventsFirst HalfIcahn SchoolMount SinaiNew York
Syndromic Multiplex Panels Market Analysis/Research Report - Vimarsana News

Syndromic Multiplex Panels Market Analysis/Research Report

Published: May 26, 2022

Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi...

Source: globenewswire.com
Related Topics:
United StatesPerkin ElmerSiemens HealthineersQiagen GmbhAkonni BiosystemsPrimerdesign NovacytMobidiag HologicPhysician OfficeBosch Healthcare Solutions GmbPublic NationalCentral LabTechnology DevelopmentMeridian Bioscience To Acquire Genepoc IncGenetic Signatures Wins Public Health Wales ContractClinical Laboratory Market SegmentsProfiles Of Key Syndromic Testing CompaniesBinx HealthCue HealthPhysician Office LabInfectious Disease Testing Firm Curative Acquires KorvalabsPanel WinsEnzo Life Sciences IncQiagen Respiratory PanelSyndromic Respiratory PanelLucira Health
Global Syndromic Multiplex Panels Markets 2022-2027: Speed of Diagnosis, Effect on Costs, PoC Advantage, Syndrome Testing, Accuracy and Diagnostic Risk, Improvement in Outcomes Driving Growth - Vimarsana News

Global Syndromic Multiplex Panels Markets 2022-2027: Speed of Diagnosis, Effect on Costs, PoC Advantage, Syndrome Testing, Accuracy and Diagnostic Risk, Improvement in Outcomes Driving Growth

Published: May 26, 2022

/PRNewswire/ -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and...

Source: prnewswire.com
Related Topics:
United StatesPerkin ElmerSiemens HealthineersQiagen GmbhAkonni BiosystemsPrimerdesign NovacytMobidiag HologicLaura WoodPhysician OfficeBosch Healthcare Solutions GmbPublic NationalCentral LabTechnology DevelopmentMeridian Bioscience To Acquire Genepoc IncGenetic Signatures Wins Public Health Wales ContractClinical Laboratory Market SegmentsProfiles Of Key Syndromic Testing CompaniesBinx HealthCue HealthPhysician Office LabInfectious Disease Testing Firm Curative Acquires KorvalabsPanel WinsEnzo Life Sciences IncQiagen Respiratory PanelSyndromic Respiratory Panel
Global Molecular Point of Care (POC) Markets Report 2021-2022 & 2026 with a Complete Update on mPOC and COVID-19 - Vimarsana News

Global Molecular Point of Care (POC) Markets Report 2021-2022 & 2026 with a Complete Update on mPOC and COVID-19

Published: May 9, 2022

/PRNewswire/ -- The "The Market and Future Potential for Molecular Point of Care (POC), 2022" report has been added to ResearchAndMarkets.com's offering. The...

Source: prnewswire.com
Related Topics:
Akonni BiosystemsLaura WoodGreiner BioSekisui DiagnosticsMolecular Market DevelopmentOffice Hours CallMolecular Sexual HealthMesa Biotech IncQuidel CorporationCompany ProfilesE St Office Hours CallGroupb StreptococcusMeridian Bioscience IncWomen Health TestingAbbott LaboratoriesQuantumdx GroupFuture PotentialMolecular PointTopics CoveredCare MarketMolecular Point Of Care Market DevelopmentLong TermBiotech StrepTests Enter MarketMolecular Point Of Care
BioMark Diagnostics, Inc.: BioMark to Present New Cancer Screening Data Using the LDTD-MS/MS Technique at the Annual ASMS Conference on Mass Spectrometry - Vimarsana News

BioMark Diagnostics, Inc.: BioMark to Present New Cancer Screening Data Using the LDTD-MS/MS Technique at the Annual ASMS Conference on Mass Spectrometry

Published: April 27, 2022

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on hard

Source: finanznachrichten.de
Related Topics:
United StatesMinneapolis Convention CenterUnited KingdomBritish ColumbiaRashid BuxRashid Ahmed BuxBiomark Diagnostics IncAmerican Society For Mass SpectrometryBritish Columbia Newsfile CorpPhytronix Technologies IncMark DiagnosticsAnnual ConferenceAmerican SocietyMass SpectrometryQuebec Based Phytronix TechnologiesQuantitative AnalysisThursday JuneLiquid HandlerBoth BiomarkLooking InformationAlthough Biomark